Standout Papers

A protein-based cGAS-STIN... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses
    2022 169 citations Xuan Wang, Yingqi Liu et al. Nature Communications profile →

Immediate Impact

2 from Science/Nature 60 hit
Sub-graph 1 of 24

Citing Papers

Inhalable nanovesicles loaded with a STING agonist enhance CAR-T cell activity against solid tumors in the lung
2025 Hit
Rational Design of Nanozymes for Engineered Cascade Catalytic Cancer Therapy
2025 Hit
3 intermediate papers

Works of Xuan Wang being referenced

A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses
2022 Hit
Tumor‐Targeted Disruption of Lactate Transport with Reactivity‐Reversible Nanocatalysts to Amplify Oxidative Damage
2021

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xuan Wang 570 475 325 259 195 79 1.3k
Kevin McDonnell 351 0.6× 331 0.7× 275 0.8× 317 1.2× 210 1.1× 33 1.7k
Kaiyuan Liu 339 0.6× 631 1.3× 172 0.5× 421 1.6× 132 0.7× 114 1.6k
Yunqing Gu 341 0.6× 136 0.3× 384 1.2× 199 0.8× 75 0.4× 71 1.1k
Yuling Yang 337 0.6× 415 0.9× 235 0.7× 559 2.2× 380 1.9× 76 1.7k
Yizhi Liu 638 1.1× 440 0.9× 235 0.7× 757 2.9× 95 0.5× 70 1.7k
G. Srinivas 273 0.5× 406 0.9× 190 0.6× 181 0.7× 398 2.0× 74 1.6k
Lisheng Zhou 175 0.3× 255 0.5× 128 0.4× 219 0.8× 289 1.5× 66 1.5k
Jing Wu 515 0.9× 779 1.6× 129 0.4× 380 1.5× 95 0.5× 60 1.7k
Ivan Anžel 426 0.7× 673 1.4× 91 0.3× 223 0.9× 53 0.3× 111 1.2k
Xinfeng Wu 494 0.9× 737 1.6× 211 0.6× 331 1.3× 74 0.4× 113 1.7k

All Works

Loading papers...

Rankless by CCL
2026